β-Lactamase inhibitor combinations with extended-spectrum penicillins: Factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa

Pharmacotherapy

Volumn 20, Issue 9 II, 2000, Pages

  Lister, P D ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEPHALOSPORINASE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; DRUG POTENCY; ENTEROBACTERIACEAE; ENZYME INDUCTION; ENZYME SYNTHESIS; IMMUNE RESPONSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 0033823040     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.14.213s.35045     Document Type: Conference Paper

References (31)

1. β-Lactamases of gram-negative bacteria: New challenges for new drugs
2. β-Lactam resistance in gram-negative bacteria: Global trends and clinical impact
3. A functional classification scheme for β-lactamases and its correlation with molecular structure
4. Characterization of β-lactamases
5. Inducible β-lactamases: Clinical and epidemiological implications for use of newer cephalosporins
6. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae
7. Penicillinase-producing gonococci in Liverpool
8. Penicillinase production by Haemophilus influenzae
9. Determinants of the activity of β-lactamase inhibitor combinations
10. Naturally occurring β-lactamase inhibitors with antibacterial activity
11. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: Initial bacteriological characterization
12. Synthesis and β-lactamase inhibitory properties of 2β-[1,2,3-triazole-1-methyl]. 2alpha-methylpenem-3alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives
13. β-Lactamase inhibitors from laboratory to clinic
14. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate
15. β-Lactamase production in members of the family Enterobacteriaceae and resistance of β-lactam-enzyme inhibitor combinations
16. Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12
17. Kinetic interactions of tazobactam with β-lactamases from all major structural classes
18. Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244
19. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: Role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests
20. Combined activity of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli
21. Antimicrobial resistance with focus on β-lactam resistance in gram-negative bacilli
22. TRC-1: Emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strain
23. Interactions of tazobactam and clavulanate with inducibly and constitutively expressed class I β-lactamase
24. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis due to in-vivo selection of stable partially derepressed β-lactamase-producing strains
25. Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: Sulbactam pharmacokinetics in pharmacodynamic interactions
26. Importance of β-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: Studies with piperacillin-tazobactam and piperacillin-sulbactam
27. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin
28. Diverse potential of β-lactamase inhibitors to induce class 1 enzymes
29. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria
30. Clavulanate and β-lactamase induction